Value Bridge — UNIVERSITY OF VIRGINIA MEDICAL CENTE
Current $25M → Target $77M (+$52.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$24.9M
Current EBITDA
$77.3M
Target EBITDA
+$52.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$11.9M
Payer Mix Optimization
$28.4M
Cost to Collect Reduction
$9.5M
Clean Claim Improvement
$7.1M
Volume & Rate Growth
$47.4M
What This Means
The 7-lever model projects a 210% EBITDA uplift from $25M to $77M. The highest-impact lever is Volume & Rate Growth at $19.0M probability-weighted.
IC talking point: "We see $52M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $576M in equity value creation."